INDICATIONS: Peripheral neuropathy Chronic fatigue syndrome Diabetic neuropathy Cardiovascular support Muscle recovery and fatigue management*
Barrington P, Chien JY, Showalter HD et al (2011) A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes
This is typically temporary and improves as intake stabilizes and weight settles
Supporting Overall Wellness Alongside Peptide Anticoagulants Alongside precision boarding for circulatory safety, Avenas patients often benefit from naturopathic consultations, where we explore how gut health, stress management, and even hormonal balance play into circulatory and immune support
Dosage and administration Typical protocols in the literature and clinical practice use subcutaneous injection , often run in a loading-then-maintenance pattern: a higher loading dose over the first 46 weeks, then a lower maintenance dose
Kang et al., 2023)